During the recent session, Outset Medical Inc (NASDAQ:OM)’s traded shares were 0.53 million, with the beta value of the company hitting 2.01. At the last check today, the stock’s price was $0.90, reflecting an intraday gain of 10.33% or $0.08. The 52-week high for the OM share is $5.22, that puts it down -480.0 from that peak though still a striking 51.11% gain since the share price plummeted to a 52-week low of $0.44. The company’s market capitalization is $48.58M, and the average intraday trading volume over the past 10 days was 0.62 million shares, and the average trade volume was 980.61K shares over the past three months.
Outset Medical Inc (OM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.80. OM has a Sell rating from 0 analyst(s) out of 8 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.41.
Outset Medical Inc (NASDAQ:OM) trade information
Outset Medical Inc (OM) registered a 10.33% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.33% in intraday trading to $0.90, hitting a weekly high. The stock’s 5-day price performance is 11.68%, and it has moved by 18.65% in 30 days. Based on these gigs, the overall price performance for the year is -71.37%. The short interest in Outset Medical Inc (NASDAQ:OM) is 9.08 million shares and it means that shorts have 5.7 day(s) to cover.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 85.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3 and $34 respectively. As a result, OM is trading at a discount of -3677.78% off the target high and -233.33% off the low.
Outset Medical Inc (OM) estimates and forecasts
In the rating firms’ projections, revenue will decrease -13.32% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 28.47M as predicted by 5 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 28.63M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 30.5M and 28.17M respectively. In this case, analysts expect current quarter sales to shrink by -6.64% and then jump by 1.63% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -15.08%. While earnings are projected to return 26.00% in 2025, the next five years will return 38.76% per annum.
OM Dividends
Outset Medical Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Outset Medical Inc (NASDAQ:OM)’s Major holders
Outset Medical Inc insiders own 2.22% of total outstanding shares while institutional holders control 53.27%, with the float percentage being 54.47%. FMR LLC is the largest shareholder of the company, while 106.0 institutions own stock in it. As of 2024-06-30, the company held over 7.7 million shares (or 15.1214% of all shares), a total value of $29.63 million in shares.
The next largest institutional holding, with 5.2 million shares, is of AMERIPRISE FINANCIAL INC’s that is approximately 10.2162% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $20.02 million.
Also, the Mutual Funds coming in first place with the largest holdings of Outset Medical Inc (OM) shares are Fidelity Select Portfolios – Medical Technology & Devices Port and Vanguard Total Stock Market Index Fund. Data provided on Dec 31, 2024 indicates that Fidelity Select Portfolios – Medical Technology & Devices Port owns about 3.3 shares. This amounts to just over 6.15 percent of the company’s overall shares, with a $2.97 million market value. The same data shows that the other fund manager holds slightly less at 1.65, or about 3.07% of the stock, which is worth about $1.48 million.
